SofWave is a cutting-edge medical cosmetic treatment that is effective in reducing sagging skin and wrinkles. It uses ultrasonic energy to target the mid-dermis, promoting collagen production and resulting in a skin tightening effect.
SOFWAVE is a next-generation treatment for sagging skin, incorporating innovative ultrasound technology.
Dubbed "the last new type of sagging treatment of the century," this treatment directly targets the middle dermis, a previously difficult target. It simultaneously lifts and improves skin quality while minimizing stress on the skin's surface.
"SUPERB™," the core technology of SOFWAVE, stands for Synchronized Ultrasound Parallel Beam.
This technology enables precise and uniform delivery of ultrasound energy to the mid-dermis, approximately 1.5 mm deep in the skin.
While traditional HYFU treatments (such as Ultherapy) primarily target the SMAS layer (fascia), SOFWAVE targets the collagen-rich mid-dermis.
This reduces facial volume loss and achieves a natural, firming finish.
Another major benefit is the simultaneous improvement of sagging and skin quality.
[US FDA Approved]
A highly reliable medical device recognized by international standards.
Clinical trials have confirmed its minimal side effects and proven effectiveness.
[Ministry of Health, Labour and Welfare Pharmaceutical Approval]
It has also passed rigorous domestic screening to ensure its suitability for Japanese users. It is the first ultrasound device approved in Japan for skin tightening.
Traditional laser treatments and lifting procedures can result in prolonged swelling and redness after the procedure. However, SoftWave is designed to minimize the impact on the epidermis, allowing you to return to your daily life immediately after treatment.
Compared to other ultrasound treatments, Sofwave is designed to be less painful. In particular, it has been successful in reducing pain by delivering energy only to the dermis layer while cooling the epidermis.
Conventional HYFU treatments (such as Ultherapy) target the fascia layer known as the SMAS, which has been cited as posing a risk of impacting the fat layer and causing facial sagging. This has led to it being considered unsuitable for slim individuals or those with little cheek fat, as it could cause sagging.
However, SofWave only targets the middle dermis, so it has minimal impact on the SMAS layer and fat layer, eliminating the risk of facial sagging.
| Both cheeks + under the chin 150 shots 42% off the regular price (monitor campaign fee) |
79,000JPY
|
| Full face + under the chin 200 shots 35% off regular price |
104,000JPY
|
| Both cheeks 100 shots |
110,000JPY
|
| Both cheeks + under the chin 150 shots |
135,000JPY
|
| Both cheeks + under the chin 150 shots 3-time course |
110,000JPY / per session
|
| Full face + Under chin 200 shots |
160,000JPY
|
| Full face + Under chin 200 shots – 3-session course |
130,000JPY / per session
|
| Full face + under the chin + neck 250 shots |
198,000JPY
|
| Full face + under the chin + neck 250 shots 3-session course |
162,000JPY / per session
|
| Additional 30 shots |
24,000JPY
|
*Implementation clinic: Osaka clinic
| Side Effects & Risks | Temporary redness/heat/mild swelling/temporary change in sensation/bruising |
| Face Washing / Bathing | Available from the same day |
| Makeup / Skincare | Available from the same day |
| Sun Exposure | Please use sunscreen on the treatment area to protect your skin from UV rays. |
| Contraindications | Pregnant or nursing women/those using internal medical devices such as pacemakers/those with severe skin diseases/those with active infections in the treatment area/those with metal implants/diabetics/those prone to keloids/those taking anticoagulants |